Overall, current human data support small sourdough-related improvements in early-phase glycemic and insulinemic responses—particularly when organic acid content is high and/or in T2D—while total glycemic exposure (iAUC), fasting glycemia and longer-term insulin sensitivity remain largely unchanged in short-term trials. This evidence concerns the gene INS and type 2 diabetes mellitus.